Detalhe da pesquisa
1.
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
Brain
; 147(3): 849-857, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936330
2.
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.
Ann Gen Psychiatry
; 23(1): 10, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38424537
3.
Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
Acta Neuropsychiatr
; : 1-7, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605630
4.
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis.
Brain Behav Immun
; 111: 211-229, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990297
5.
Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression.
Bipolar Disord
; 25(2): 99-109, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516343
6.
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia.
CNS Spectr
; 28(5): 541-560, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268655
7.
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis.
Brain Behav Immun
; 101: 93-135, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973396
8.
Lumateperone for the Treatment of Adults With Schizophrenia: a Systematic Review.
Curr Psychiatry Rep
; 24(8): 359-368, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802228
9.
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series.
Am J Geriatr Psychiatry
; 29(9): 899-913, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33478865
10.
Corrigendum to "COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis" [Brain Behav. Immun. 111 (2023) 211-229].
Brain Behav Immun
; 115: 758, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806865
11.
Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression.
J Psychopharmacol
; 38(4): 375-381, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477185
12.
A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.
J Affect Disord
; 350: 698-705, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244804
13.
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
J Affect Disord
; 355: 342-354, 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570038
14.
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.
Adv Ther
; 41(5): 1983-1994, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520501
15.
Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
Curr Med Res Opin
; : 1-7, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860901
16.
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis.
Expert Opin Pharmacother
; 25(1): 5-14, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164653
17.
Oral ketamine for depression: An updated systematic review.
World J Biol Psychiatry
; 24(7): 545-557, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651238
18.
Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder.
J Psychopharmacol
; 37(3): 313-317, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36377525
19.
Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder.
J Affect Disord
; 340: 893-898, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37557991
20.
Biomarkers of ketamine's antidepressant effect: An umbrella review.
J Affect Disord
; 323: 598-606, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521662